Antitumor activity of cytokine-induced killer cells against human lung cancer.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMID 17996691)

Published in Int Immunopharmacol on September 07, 2007

Authors

Hwan Mook Kim1, Jaeseung Lim, Song-Kyu Park, Jong Soon Kang, Kiho Lee, Chang Woo Lee, Ki Hoon Lee, Mi-Jung Yun, Kyu-Hwan Yang, Gyoonhee Han, Soon Woo Kwon, Youngsoo Kim, Sang-Bae Han

Author Affiliations

1: Bioevaluation center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Chungbuk 363-883, South Korea.

Articles citing this

Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC). J Cancer Res Clin Oncol (2010) 1.67

Experimental approaches for the treatment of malignant gliomas. Pharmacol Ther (2010) 1.23

Cytokine-induced killer cells promote antitumor immunity. J Transl Med (2013) 1.16

Growth of human colorectal cancer SW1116 cells is inhibited by cytokine-induced killer cells. Clin Dev Immunol (2010) 0.90

Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models. Front Oncol (2012) 0.90

Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells. Immune Netw (2015) 0.81

T-Bet Mediated Anti-Neoplastic Effects of Dendritic Cell-Cytokine Induced Killer Cells in vitro. Iran J Pediatr (2012) 0.81

Synergistic effect of cytokine-induced killer cell with valproate inhibits growth of hepatocellular carcinoma cell in a mouse model. Cancer Biol Ther (2017) 0.76

Breast cancer cells evade paclitaxel-induced cell death by developing resistance to dasatinib. Oncol Lett (2016) 0.75

Inhibition of human pancreatic tumor growth by cytokine-induced killer cells in nude mouse xenograft model. Immune Netw (2012) 0.75

An engineered three-dimensional gastric tumor culture model for evaluating the antitumor activity of immune cells in vitro. Oncol Lett (2012) 0.75

Cord blood-derived cytokine-induced killer cellular therapy plus radiation therapy for esophageal cancer: a case report. Medicine (Baltimore) (2014) 0.75

Articles by these authors

Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell (2002) 5.69

The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res (2012) 5.04

Physical properties and collapse force of according to the z-position of poly-Si pattern using nano-tribology. J Nanosci Nanotechnol (2011) 1.88

Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability. Cancer Cell (2003) 1.78

Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood (2010) 1.77

Ketonethiosemicarbazones: structure-activity relationships for their melanogenesis inhibition. Bioorg Med Chem Lett (2011) 1.60

Downregulation of c-FLIP sensitizes DU145 prostate cancer cells to Fas-mediated apoptosis. Cancer Biol Ther (2002) 1.58

Transient receptor potential canonical type 3 channels facilitate endothelium-derived hyperpolarization-mediated resistance artery vasodilator activity. Cardiovasc Res (2012) 1.56

Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells. Arch Pharm Res (2010) 1.55

Induction of dendritic cell maturation by β-glucan isolated from Sparassis crispa. Int Immunopharmacol (2010) 1.53

Protective role of autophagy in palmitate-induced INS-1 beta-cell death. Endocrinology (2008) 1.52

Kisspeptin excites gonadotropin-releasing hormone neurons through a phospholipase C/calcium-dependent pathway regulating multiple ion channels. Endocrinology (2008) 1.51

Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-kappaB without affecting IkappaB degradation. FEBS Lett (2004) 1.48

Toll-like receptor signaling alters the expression of regulator of G protein signaling proteins in dendritic cells: implications for G protein-coupled receptor signaling. J Immunol (2004) 1.47

Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3. Clin Cancer Res (2006) 1.46

Relation between electrical properties of aerosol-deposited BaTiO3 thin films and their mechanical hardness measured by nano-indentation. Nanoscale Res Lett (2012) 1.32

Structural requirement(s) of N-phenylthioureas and benzaldehyde thiosemicarbazones as inhibitors of melanogenesis in melanoma B 16 cells. Bioorg Med Chem Lett (2010) 1.32

JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin. J Inflamm (Lond) (2008) 1.30

Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signaling. Hepatology (2010) 1.23

Oxyresveratrol and hydroxystilbene compounds. Inhibitory effect on tyrosinase and mechanism of action. J Biol Chem (2002) 1.21

Identification of novel PPARgamma target genes in primary human adipocytes. Gene (2005) 1.20

Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors. Bioorg Med Chem Lett (2006) 1.19

Rgs5 targeting leads to chronic low blood pressure and a lean body habitus. Mol Cell Biol (2008) 1.19

GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer. Clin Cancer Res (2008) 1.18

The transcription factor GLI1 mediates TGFβ1 driven EMT in hepatocellular carcinoma via a SNAI1-dependent mechanism. PLoS One (2012) 1.17

Effects of alpha-lipoic Acid on body weight in obese subjects. Am J Med (2011) 1.15

Crystal structure of PilF: functional implication in the type 4 pilus biogenesis in Pseudomonas aeruginosa. Biochem Biophys Res Commun (2005) 1.15

Human microRNA-27a* targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity. Blood (2011) 1.15

Synthesis of amide and urea derivatives of benzothiazole as Raf-1 inhibitor. Eur J Med Chem (2007) 1.11

Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2002) 1.11

Nonclassical estrogen modulation of presynaptic GABA terminals modulates calcium dynamics in gonadotropin-releasing hormone neurons. Endocrinology (2008) 1.11

Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients. Proteomics (2007) 1.11

Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1beta and prostaglandin E2 synthesis by silymarin. Biochem Pharmacol (2004) 1.10

The triterpenoid CDDO induces apoptosis in refractory CLL B cells. Blood (2002) 1.10

Production of biallelic CMP-Neu5Ac hydroxylase knock-out pigs. Sci Rep (2013) 1.08

An intact sialoadhesin (Sn/SIGLEC1/CD169) is not required for attachment/internalization of the porcine reproductive and respiratory syndrome virus. J Virol (2013) 1.08

O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells. Exp Cell Res (2008) 1.07

Toll-like receptor 4-dependent activation of macrophages by polysaccharide isolated from the radix of Platycodon grandiflorum. Int Immunopharmacol (2003) 1.06

Involvement of Ca2+-mediated apoptotic signals in palmitate-induced MIN6N8a beta cell death. Mol Cell Endocrinol (2007) 1.05

Fast synthesis of high-performance graphene films by hydrogen-free rapid thermal chemical vapor deposition. ACS Nano (2014) 1.02

Roles for phosphoinositide 3-kinases, Bruton's tyrosine kinase, and Jun kinases in B lymphocyte chemotaxis and homing. Eur J Immunol (2006) 1.02

T cell Ig domain and mucin domain 1 engagement on invariant NKT cells in the presence of TCR stimulation enhances IL-4 production but inhibits IFN-gamma production. J Immunol (2010) 1.01

Reduction in synaptic GABA release contributes to target-selective elevation of PVN neuronal activity in rats with myocardial infarction. Am J Physiol Regul Integr Comp Physiol (2010) 1.01

Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Arch Pharm Res (2009) 1.00

Ethyl pyruvate has an anti-inflammatory effect by inhibiting ROS-dependent STAT signaling in activated microglia. Free Radic Biol Med (2008) 0.99

Enhanced permeability of the antimicrobial agent 2,5-bis(4-amidinophenyl)furan across Caco-2 cell monolayers via its methylamidoidme prodrug. Pharm Res (2002) 0.98

Isolation and structure determination of streptochlorin, an antiproliferative agent from a marine-derived Streptomyces sp. 04DH110. J Microbiol Biotechnol (2007) 0.98

Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells. Toxicol Appl Pharmacol (2002) 0.98

Deacylation activity of cephalosporin acylase to cephalosporin C is improved by changing the side-chain conformations of active-site residues. Biochem Biophys Res Commun (2003) 0.98

Cinnamaldehyde and 2-methoxycinnamaldehyde as NF-kappaB inhibitors from Cinnamomum cassia. Planta Med (2004) 0.97

Antitumor activity of cytokine-induced killer cells in nude mouse xenograft model. Arch Pharm Res (2009) 0.97

B cells productively engage soluble antigen-pulsed dendritic cells: visualization of live-cell dynamics of B cell-dendritic cell interactions. J Immunol (2005) 0.97

Giant vascular eccrine spiradenoma: report of a case with immunohistochemical study. J Korean Med Sci (2006) 0.97

Interactions at a dioxin responsive element (DRE) and an overlapping kappaB site within the hs4 domain of the 3'alpha immunoglobulin heavy chain enhancer. Toxicology (2004) 0.97

Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models. J Neuroinflammation (2012) 0.96

Phosphorylation of hepatitis B virus Cp at Ser87 facilitates core assembly. Biochem J (2006) 0.96

Crystal structure of the N-terminal domain of anaphase-promoting complex subunit 7. J Biol Chem (2008) 0.96

HBXIP, cellular target of hepatitis B virus oncoprotein, is a regulator of centrosome dynamics and cytokinesis. Cancer Res (2006) 0.96

RhoB induces apoptosis via direct interaction with TNFAIP1 in HeLa cells. Int J Cancer (2009) 0.96

Antagonism of aryl hydrocarbon receptor-dependent induction of CYP1A1 and inhibition of IgM expression by di-ortho-substituted polychlorinated biphenyls. Toxicol Appl Pharmacol (2003) 0.96

Improvement of high-fat diet-induced obesity by a mixture of red grape extract, soy isoflavone and L-carnitine: implications in cardiovascular and non-alcoholic fatty liver diseases. Food Chem Toxicol (2011) 0.96

O-GlcNAcylation disrupts glyceraldehyde-3-phosphate dehydrogenase homo-tetramer formation and mediates its nuclear translocation. Biochim Biophys Acta (2008) 0.96

The effect of residual silk sericin on the structure and mechanical property of regenerated silk filament. Int J Biol Macromol (2007) 0.96

Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model. Exp Mol Med (2008) 0.96

Inhibitory effect of obovatol on nitric oxide production and activation of NF-kappaB/MAP kinases in lipopolysaccharide-treated RAW 264.7cells. Eur J Pharmacol (2006) 0.96

LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1alpha via upregulation of VHL in a colon cancer cell line. Biochem Pharmacol (2010) 0.96

Inhibition of human ovarian tumor growth by cytokine-induced killer cells. Arch Pharm Res (2007) 0.95

Myeloid differentiation 2 as a therapeutic target of inflammatory disorders. Pharmacol Ther (2011) 0.95

Preclinical evaluation of the toxicological effects of a novel constrained ethyl modified antisense compound targeting signal transducer and activator of transcription 3 in mice and cynomolgus monkeys. Nucleic Acid Ther (2013) 0.95